Angeles Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Angeles Wealth Management's IBB Position: Q3 2026 in Review
Angeles Wealth Management held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 237 shares worth $49.9K. The position accounts for ﹤0.01% of the portfolio, ranked #536.
Angeles Wealth Management first reported a position in IBB in Q2 2024 and has held it in 10 quarters since. The position peaked at $69.3K in Q4 2024. 1,030 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Angeles Wealth Management held 237 shares of iShares Biotechnology ETF worth $49.9K as of Q3 2026.
- Angeles Wealth Management left its iShares Biotechnology ETF share count unchanged in Q3 2026.
- iShares Biotechnology ETF made up ﹤0.01% of Angeles Wealth Management's portfolio in Q3 2026, its #536 holding.
- Angeles Wealth Management first reported a position in iShares Biotechnology ETF in Q2 2024 and has held it in 10 quarters since.
- Angeles Wealth Management's iShares Biotechnology ETF position peaked at $69.3K in Q4 2024.
- 1,030 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Angeles Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.